Clinical Trials in Phoenix

Showing 5681-5700 of 16,646 trials

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

NCT06344052

The goal of this clinical trial is to evaluate the efficacy of using SP-002 in participants with locally advanced Basal cell carcinoma. The main question it aims to answer is what the objective response rate for a basal cell carcinoma tumor is following 1 or 3 cycles of SP-002 treatment given as an add-on to hedgehog pathway inhibitor therapy. Researchers will compare the objective response rate for treated Basal cell carcinoma tumors between 3 treatment Arms. * Arm 1 participants will receive daily hedgehog pathway inhibitor, and 3 cycles of SP-002 treatment. * Arm 2 participants will receive daily hedgehog pathway inhibitor, and 1 cycle of SP-002 treatment. * Arm 3 participants will receive daily hedgehog pathway inhibitor only.

Basal Cell Carcinoma

Stamford Pharmaceuticals, Inc.80 participantsStarted Apr 2024

Phoenix, Arizona, United States • Boca Raton, Florida, United States • Coral Springs, Florida, United States +7 more locations

TERMINATEDPhase 29.8 miles

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

NCT05567783

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIR-2482 compared to placebo in preventing influenza A illness in healthy adults 18 to \<65 years of age without pre-existing risk factors for serious complications from influenza infection.

Influenza A

Vir Biotechnology, Inc.2,977 participantsStarted Oct 2022

Anniston, Alabama, United States • Mobile, Alabama, United States • Tempe, Arizona, United States +48 more locations

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Find Trials by Condition in Phoenix

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

A Safety and Efficacy Study in Patients With Gastric Cancer

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Air Optix® Night and Day® Aqua Continuous Wear

Umbilical Cord Milking in Non-Vigorous Infants

Encore PFO Closure Device - The PerFOrm Trial

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Palbociclib in Real World Practice

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities